NCT Number: NCT05478239
Phase: PHASE2
Trial Summary: Until now, clinicians have been challenged to improve the treatment of biochemically recurrent (BCR) prostate cancer in which prostatic specific antigen (PSA) rises without radiological or clinical pr – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Zin W Myint
Acronym:
ArtemiCoffee in Patients With Rising PSA
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives